Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 130, Issue 3, Pages (March 2006)
Volume 148, Issue 2, Pages e7 (February 2015)
Jasper Zu Putlitz*, Stefan Wieland‡, Hubert E. Blum‡, Jack R. Wands* 
Volume 136, Issue 1, Pages e2 (January 2009)
R. Cavallo  Clinical Microbiology and Infection 
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B 
Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection  D.K.-H. Wong, J. Fung, C.-K. Lee, W.-K.
Hepatitis C virus infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 141, Issue 2, Pages e3 (August 2011)
Volume 65, Issue 4, Pages (October 2016)
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation—an insight from.
Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population  Y.-Q. Tong, B. Liu,
Prediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation.
Volume 140, Issue 2, Pages (February 2011)
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Volume 130, Issue 3, Pages (March 2006)
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
Volume 124, Issue 7, Pages (June 2003)
Volume 148, Issue 2, Pages e7 (February 2015)
R. Cantón  Clinical Microbiology and Infection 
Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection  Y.W.
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy  M. Pollicita, C. Alteri, M.C.
How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?  Neil Rajoriya,
F. Li, P. Zhou, W. Deng, J. Wang, R. Mao, Y. Zhang, J. Li, J. Yu, F
Volume 44, Issue 5, Pages (May 2006)
L. -W. Song, P. -G. Liu, C. -J. Liu, T. -Y. Zhang, X. -D. Cheng, H. -L
Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population  Y.-Q. Tong, B. Liu,
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Volume 68, Issue 4, Pages (April 2018)
Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing  F. Li, D. Zhang, Y. Li, D. Jiang, S. Luo, N. Du,
Jasper Zu Putlitz*, Stefan Wieland‡, Hubert E. Blum‡, Jack R. Wands* 
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Circulation of a novel human respiratory syncytial virus Group B genotype during the 2014–2015 season in Catalonia (Spain)  L. Gimferrer, C. Andrés, M.
Cases of travel-acquired dengue fever in Denmark 2001–2009
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus.
Hepatitis B and C virus-related carcinogenesis
Volume 42, Issue 3, Pages (March 2005)
Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected.
New developments in laboratory monitoring of HIV-1 infection
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
HBV subgenotype misclassification expands quasi-subgenotype A3
A. McNally, F. Alhashash, M. Collins, A. Alqasim, K. Paszckiewicz, V
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Volume 128, Issue 3, Pages (March 2005)
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic.
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Clinical Microbiology and Infection
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients  H.-Y. Pan, H.-Y. Pan,
Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains  P. Trémeaux, A. Caporossi,
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
J.L. Balcázar  Clinical Microbiology and Infection 
Molecular epidemiology of hepatitis B virus in Iran
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full- length sequencing in a nationwide cohort study and evolutionary.
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
PML influences HBV transcription, expression, and replication through the HBV basal core promoter. PML influences HBV transcription, expression, and replication.
Presentation transcript:

Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro  E. Shirvani-Dastgerdi, M.R. Pourkarim, U. Herbers, S. Amini-Bavil-Olyaee, E. Yagmur, S.M. Alavian, C. Trautwein, F. Tacke  Clinical Microbiology and Infection  Volume 22, Issue 1, Pages 98.e1-98.e6 (January 2016) DOI: 10.1016/j.cmi.2015.09.020 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Hepatitis B virus (HBV) genome alterations in HBV/hepatitis delta virus (HDV)-infected patients and functional impact of HDV on the replication of HBV polymerase and envelope mutants. (a) Comparison of amino acid substitution rates (dN/dS) for the small hepatitis B surface antigen (S-HBsAg) and the reverse transcriptase (rt) domain between HBV-mono-infected (control, black) and HBV/HDV-infected (case, red) patients. (b, c) Huh7 human hepatoma cells were transiently transfected with replication-competent HBV plasmids (5 μg, genotype A, subtype adw2). In comparison with mono-transfection (S = single, dark grey), the effect of co-transfection with wild-type HDV genotype 1 (1 μg, D = double, light grey) on HBV replication was studied. Intracellular HBV progeny DNA levels ((b) representative Southern blot after immunoprecipitation for anti-HBc and statistics) and released HBV virions ((c), representative Southern blot and statistics) are shown. Results are from three or more independent experiments with two biological duplicates each. Ag loop, antigenic loop DL, double-stranded linear form (3.2 kb); DM, LAM resistance double mutation (rtL180M + rtM204V); LAM, lamivudine; pBS, pBluescript (negative control); RC, relaxed circular form (4.0 Kb); SM, LAM resistance single mutation (rtM204I); SS, HBV DNA full-length single-stranded form (1.5 kb); TMD, transmembrane domain; wt, wild-type HBV. Clinical Microbiology and Infection 2016 22, 98.e1-98.e6DOI: (10.1016/j.cmi.2015.09.020) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Frequency of mutations in hepatitis B virus (HBV) replication/transcription-controlling elements, functional impact of hepatitis delta virus (HDV) on the replication of HBV precore (PC)-containing or basal core promoter (BCP)-containing mutants, and effects of mutant HBV on HDV replication. (a) Comparison of HBV nucleotide changes between HBV-infected (control, dark blue) and HBV/HDV-infected (case, light blue) patients at HBV enhancer domains (EnhI and EnhII) and transcription control motifs (Box-β, BCP, and PC). n represents the number of patients included in the analyses. (b–e) Huh7 human hepatoma cells were transiently transfected with replication-competent HBV plasmids (5 μg, genotype A, subtype adw2) containing different mutations in conjunction with PC or BCP mutations. In comparison with mono-transfection (S = single, dark grey), the effect of co-transfection with wild-type HDV genotype 1 (1 μg, D = double, light grey) on HBV replication was studied. Intracellular HBV progeny DNA levels ((b) representative Southern blot after immunoprecipitation for anti-HBc and statistics) and released HBV virions ((c) representative Southern blot and statistics) are shown. Intracellular HDV genomic RNA levels (d) and extracellular HDV RNA levels in the supernatant (e) of co-transfected cells were assessed by northern blot. Results are from three or more independent experiments with two biological duplicates each. DL, double-stranded linear form (3.2 kb); DM, LAM resistance double mutation (rtL180M + rtM204V); LAM, lamivudine; pBS, pBluescript (negative control); RC, relaxed circular form (4.0 kb); SM, LAM resistance single mutation (rtM204I); SS, HBV DNA full-length single-stranded form (1.5 kb); wt, wild-type HBV. Clinical Microbiology and Infection 2016 22, 98.e1-98.e6DOI: (10.1016/j.cmi.2015.09.020) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions